| # |
Company Name
|
Industry Name
|
Latest Price (Rs.)
|
Price Change
Rs (%) |
Market Cap
|
Net Sales
(Rs. Cr.) |
Latest EPS
(Rs.) |
Net Profit
Margin % |
Latest
P/E |
Latest
P/BV |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma Inds. | Pharmaceuticals& Drugs | 1,779.4 |
-10.1 (-0.56%) |
Large Cap | 52,578 | 47.8 | 21.55 | 37.2 | 5.1 | |
| Cipla | Pharmaceuticals& Drugs | 1,397.8 |
22.7 (1.65%) |
Large Cap | 28,163 | 48 | 13.45 | 29.1 | 3.3 | |
| Torrent Pharma | Pharmaceuticals& Drugs | 4,337.7 |
-31.85 (-0.73%) |
Large Cap | 13,980 | 63.9 | 16.41 | 67.9 | 17.5 | |
| Divis Lab | Pharmaceuticals& Drugs | 6,594.5 |
19.55 (0.3%) |
Large Cap | 9,360 | 96.7 | 23.08 | 68.2 | 10.4 | |
| Apollo Hospital Ent. | Hospital &HealthcareServices | 8,249.3 |
-34.25 (-0.41%) |
Large Cap | 8,202 | 103.8 | 15.81 | 79.5 | 11.9 |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: